SSM: Infrastructure Services Leader - Government's Golden Child Gets No Respect
Service Stream trades at $2.07 vs $3.09 fair value (49% upside). EBITDA margins expanding to 6.5%, ROIC 13.2%, net cash $74m.
View noteService Stream trades at $2.07 vs $3.09 fair value (49% upside). EBITDA margins expanding to 6.5%, ROIC 13.2%, net cash $74m.
View noteTrading at $1.48 vs $2.61 fair value (76% upside). Transform-UTM private brand validates strategic transformation. 25% market share, 89 NPS, debt-free balance sheet.
View noteHOLD rating with $8.31 fair value. Exceptional 46.2% EBITDA margins face inevitable compression as 74% ROIC attracts competition. Income-focused opportunity only.
View notePre-revenue gold explorer trading at A$0.047 vs A$0.191 fair value. Dual catalysts: systematic exploration across 1,000km² Eastern Goldfields tenure and US$50m arbitration award. High risk, asymmetric upside.
View noteHOLD rating with $1.78 fair value vs $1.99 current price. Strong 80% annuity model offset by margin compression risks and 53% valuation premium to peers.
View noteMedical device manufacturer with 35-40% oral appliance market share. Fair value $0.30 vs current $0.70. EBITDA margins compressing, manufacturing constraints binding.
View noteSoul Patts trades at $38.71 vs fair value $45.81, offering 18.4% upside through portfolio evolution and private market access with 122-year dividend track record.
View noteBUY rating with A$4.76 fair value vs A$2.36 current price. Strong balance sheet, operational excellence, 102% upside potential despite commodity volatility.
View noteSpeculative buy with 124% upside to $9.06 fair value. Binary TRL-6 catalyst Q4 2025. Revolutionary laser enrichment technology targeting 8% Western market share.
View noteElectrical contractor riding data centre wave faces inevitable margin compression. Fair value $1.55 vs current $2.97. EBITDA margins 9.0%, ROIC 84%, but competition emerging.
View noteSonic Healthcare trades at A$28.30 versus A$32.41 fair value, offering 14.5% upside through LADR integration targeting A$130m synergies with 65% achieved.
View noteSHAPE trades at $4.28 vs fair value $3.30. Strong operations (86% Perfect Delivery, 78.6% ROIC) but execution complexity and cycle timing create unfavourable risk-reward.
View note